Tharimmune, Inc. Common Stock
THARTharimmune, Inc. (THAR) is a biotechnology company focused on developing innovative diagnostic and therapeutic solutions for immune-related diseases. Utilizing advanced immunoassay technologies, Tharimmune aims to improve disease detection, monitor immune responses, and develop targeted treatments, primarily serving the healthcare and biotech sectors.
Company News
Five Nasdaq-listed stocks significantly outperformed the index in August, with gains ranging from 188% to 378%, driven by factors like drug development progress, FDA approvals, and strategic partnerships.
U.S. stock futures were slightly lower as the Jackson Hole Economic Symposium begins, with focus on Federal Reserve Chair Jerome Powell's upcoming speech and key corporate earnings reports from Walmart, Intuit, and Ross Stores.
The Dow Jones index closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transacti...
Shares of Hello Group Inc. (NASDAQ: MOMO) jumped in pre-market trading after reporting results for the third quarter. The company said net revenues decreased by 5.9% year-over-year to RMB3,042.8 million ($417.1 million) during the third quarter. Non-GAAP diluted net income per ADS rose to RMB3.05 (US$0.42) from RMB2.60 in the year-ago period. He...
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Tuesday. The Dow traded up 0.27% to 35,429.20 while the NASDAQ rose 0.12% to 14,258.32. The S&P 500 also rose, gaining, 0.07% to 4,553.52. Check This Out: How To Make $500 A Month With Microsoft As The Stock Hits An All-Time High  Leading...
